New patent expiration for Astrazeneca Ab drug BYDUREON PEN
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent expiration for Astrazeneca Ab drug BYDUREON PEN appeared first on DrugPatentWatch – Make Better Decisions.
Comments are closed.